Release Summary

Dr. Geert Cauwenbergh, will present at the 15th Annual BIO CEO & Investor Conference on Monday, February 11th at 4:00pm ET. Dr. Cauwenbergh will discuss the development of RXI-109.

RXi Pharmaceuticals Corporation